Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study.

Cuatrecasas G, Riudavets C, Güell MA, Nadal A.

BMC Musculoskelet Disord. 2007 Nov 30;8:119.

2.

Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia.

Cuatrecasas G, Alegre C, Fernandez-Solà J, Gonzalez MJ, Garcia-Fructuoso F, Poca-Dias V, Nadal A, Cuatrecasas G, Navarro F, Mera A, Lage M, Peinó R, Casanueva F, Liñan C, Sesmilo G, Coves MJ, Izquierdo JP, Alvarez I, Granados E, Puig-Domingo M.

Pain. 2012 Jul;153(7):1382-9. doi: 10.1016/j.pain.2012.02.012.

PMID:
22465047
3.

A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia.

Bennett RM, Clark SC, Walczyk J.

Am J Med. 1998 Mar;104(3):227-31.

PMID:
9552084
5.

A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia.

Jones KD, Burckhardt CS, Deodhar AA, Perrin NA, Hanson GC, Bennett RM.

Arthritis Rheum. 2008 Feb;58(2):612-22. doi: 10.1002/art.23203.

6.

Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).

Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.

Growth Horm IGF Res. 2008 Aug;18(4):307-17. doi: 10.1016/j.ghir.2007.12.001.

PMID:
18282776
7.

Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.

Ahmad AM, Hopkins MT, Thomas J, Ibrahim H, Fraser WD, Vora JP.

Clin Endocrinol (Oxf). 2001 Jun;54(6):709-17.

PMID:
11422104
8.

Serum ghrelin levels but not GH, IGF-1 and IGFBP-3 levels are altered in patients with fibromyalgia syndrome.

Tander B, Atmaca A, Aliyazicioglu Y, Canturk F.

Joint Bone Spine. 2007 Oct;74(5):477-81.

PMID:
17689128
9.

High prevalence of growth hormone deficiency in severe fibromyalgia syndromes.

Cuatrecasas G, Gonzalez MJ, Alegre C, Sesmilo G, Fernandez-Solà J, Casanueva FF, Garcia-Fructuoso F, Poca-Dias V, Izquierdo JP, Puig-Domingo M.

J Clin Endocrinol Metab. 2010 Sep;95(9):4331-7. doi: 10.1210/jc.2010-0061.

PMID:
20631018
10.

Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.

Lo J, You SM, Canavan B, Liebau J, Beltrani G, Koutkia P, Hemphill L, Lee H, Grinspoon S.

JAMA. 2008 Aug 6;300(5):509-19. doi: 10.1001/jama.300.5.509.

11.

Fibromyalgic syndromes: could growth hormone therapy be beneficial?

Cuatrecasas G.

Pediatr Endocrinol Rev. 2009 Jun;6 Suppl 4:529-33. Review.

PMID:
19550388
12.
13.

[Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].

Hou L, Luo XP, Du ML, Ma HM, Gong CX, Li YC, Shen SX, Zhao ZH, Liang L, Dong GP, Yan CY, Du HW.

Zhonghua Er Ke Za Zhi. 2009 Jan;47(1):48-52. Chinese.

PMID:
19573383
14.

Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.

Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG; American Norditropin Study Group..

J Clin Endocrinol Metab. 2007 Jul;92(7):2480-6.

PMID:
17356043
15.

Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.

Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A.

J Clin Endocrinol Metab. 2000 Oct;85(10):3720-5.

PMID:
11061530
16.

Exercise and obesity in fibromyalgia: beneficial roles of IGF-1 and resistin?

Bjersing JL, Erlandsson M, Bokarewa MI, Mannerkorpi K.

Arthritis Res Ther. 2013 Feb 27;15(1):R34. doi: 10.1186/ar4187.

17.

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.

Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.

Arthritis Rheum. 2004 Sep;50(9):2974-84.

18.

GH/IGF1 axis disturbances in the fibromyalgia syndrome: is there a rationale for GH treatment?

Cuatrecasas G, Alegre C, Casanueva FF.

Pituitary. 2014 Jun;17(3):277-83. doi: 10.1007/s11102-013-0486-0. Review.

PMID:
23568565
19.

The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW, Hurley D.

J Clin Endocrinol Metab. 1998 Jan;83(1):107-16.

PMID:
9435425
20.

Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.

Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S.

J Bone Miner Res. 1998 May;13(5):891-9.

Items per page

Supplemental Content

Support Center